Pharcef S 500mg/250mg Injection
Marketer
Biophar Lifesciences Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Pharcef S 500mg/250mg Injection
Cefixime and Sulbactam 500mg/250mg Injection is a dual-action antibiotic. It's indicated for a range of bacterial infections, inhibiting microbial proliferation and halting infection spread. Administration must be overseen by a medical professional. Adhere strictly to your prescribed dosage schedule; complete the entire course, even with symptom improvement. Premature cessation can compromise efficacy. Potential side effects include, but aren't limited to, nausea, vomiting, diarrhea, and dyspepsia. Report any worsening symptoms to your physician. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their doctor before use. Alcohol should be avoided due to potential increased drowsiness. While it generally doesn't affect driving ability, refrain from driving if drowsiness or dizziness occurs. Ensure adequate rest, proper nutrition, and sufficient hydration for optimal recovery. Your doctor might order blood tests and other diagnostic procedures to monitor treatment response.
Uses of Pharcef S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Pharcef S 500mg/250mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Pharcef S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Pharcef S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Pharcef S 500mg/250mg Injection works:
Ceftriaxone/Sulbactam (Pharcef S 500mg/250mg Injection) combines a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam counteracts bacterial resistance mechanisms, thereby optimizing Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Pharcef S 500mg/250mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Pharcef S 500mg/250mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Pharcef S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Pharcef S 500mg/250mg Injection may cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving is strongly discouraged while experiencing these effects.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Pharcef S 500mg/250mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The administration of Pharcef S 500mg/250mg Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Altering the dosage of Pharcef S 500mg/250mg Injection is not suggested for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Pharcef S 500mg/250mg Injection :
Omit a scheduled dose of Pharcef S 500mg/250mg Injection? Seek immediate medical advice.
Facts to Know About Pharcef S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infectives |
3,018 People bought this recently